Dr. Agarwal’s Health Care Limited

Company Profile
Company Name Dr. Agarwal’s Health Care Limited
Open Date 29-01-2025
Close Date 31-01-2025
Exchange BSE, NSE
Lot Size 35 Shares
Issue Price ₹279 to ₹294 per share
Issue Size 7,53,04,970 shares
Application Amount ₹ 14,070 – ₹ 1,96,980 (35 to 490 shares)
Recommendation Avoid

Dr. Agarwal’s Health Care Limited was originally incorporated on April 19, 2010. The registered office is located at Chennai, Tamil Nadu, India. The company provide a comprehensive range of eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lens and accessories, and eye care related pharmaceutical products. The major revenue stream for the company is from eye Surgeries. The company 737 doctors and 4,858 employees (including paramedical staff) as of September 30, 2024.

(Read more on the review)

Financial Summary in Cr

KPI’s FY 22 FY 23 FY 24 Sep-24
Revenue 696.08 1,017.98 1,332.15 820.06
EBITDA 182.12 270.35 362.26 210.60
Net Profit 43.16 103.23 95.05 39.56
RoCE 10.30% 9.32% 8.16% 9.17%*
ROE 20.32% 16.40% 7.10% 4.29%*
P/E 219.67 100.50 128.43 160.48*

Tentative Timeline

Opening Date 29/01/2025
Closing Date 31-01-2025
Basis of Allotment 03-02-2025
Initiation of Refunds 04-02-2025
Credit of Shares to Demat 04-02-2025
Listing Date 05-02-2025

Objects of the Issue

Repayment/prepayment, in part or full, of certain of the borrowings
General corporate purposes and unidentified inorganic acquisition

Contact Information

Registered Office Dr. Agarwal's Health Care Limited 1 st Floor, Buhari Towers No.4, Moores Road, Off Greams Road, Near Asan Memorial School, Chennai 600 006
Phone +91 44 4378 7777
Email secretarial@dragarwal.com
Website https://dragarwals.co.in/

Registrar Details

Name Kfin Technologies Limited
Phone 04067162222, 04079611000
Email ahcl.ipo@kfintech.com
Website https://kosmic.kfintech.com/ipostatus/

IPO Reservation

QIB Shares Offered Not more than 50% of the Net Issue
Retail Shares Offered Not less than 35% of the Net Issue
NII (HNI) Shares Offered Not less than 15% of the Net Issue

Shareholding Pattern

Share Holding Pre Issue (Promoters) 37.73%
Share Holding Post Issue (Promoters) 32.53%

Contact Us to Enable Your Success!